KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Other Accumulated Expenses (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Other Accumulated Expenses readings, the most recent being $3.7 billion for Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 22.24% to $3.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $3.7 billion, a 22.24% increase, with the full-year FY2025 number at $3.3 billion, up 4.06% from a year prior.
  • Other Accumulated Expenses hit $3.7 billion in Q1 2026 for Thermo Fisher Scientific, up from $3.3 billion in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $3.7 billion in Q1 2026 to a low of $2.8 billion in Q3 2023.
  • Median Other Accumulated Expenses over the past 5 years was $3.2 billion (2024), compared with a mean of $3.2 billion.
  • Biggest five-year swings in Other Accumulated Expenses: soared 58.89% in 2022 and later fell 11.17% in 2023.
  • Thermo Fisher Scientific's Other Accumulated Expenses stood at $3.4 billion in 2022, then decreased by 3.22% to $3.2 billion in 2023, then fell by 1.45% to $3.2 billion in 2024, then grew by 4.06% to $3.3 billion in 2025, then rose by 10.96% to $3.7 billion in 2026.
  • The last three reported values for Other Accumulated Expenses were $3.7 billion (Q1 2026), $3.3 billion (Q4 2025), and $3.2 billion (Q3 2025) per Business Quant data.